Skip to main content

14-06-2019 | Rheumatoid arthritis | EULAR 2019 | Article

Researcher comment: The FINCH 1 trial

​​​​​​Bernard Combe takes us through the findings from the FINCH 1 trial of filgotinib in rheumatoid arthritis patients with an inadequate response to methotrexate (7:19).

Related topics

Have your say on Medicine Matters

Visit the conference hub

Image Credits